Position in PFE
as of Jun 30, 2026
· filed Sep 8, 2026
Position Value
$153,696,066
New position
Shares Held
6,382,727
first reported quarter
Ownership
0.112%
of shares outstanding
% of Portfolio
0.59%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 93%
Shared 0%
None 7%
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Nykredit A/S holds $1,249,554,493 across 11 Drug Manufacturers - General names. PFE ranks #3 (12.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
327,588 | $392,918,907 | |
| 2 | JNJ |
Johnson & Johnson
|
928,551 | $235,824,097 | |
| 3 | PFE |
Pfizer Inc
This page
|
6,382,727 | $153,696,066 | |
| 4 | ABBV |
AbbVie Inc.
|
596,240 | $150,037,833 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
1,112,764 | $140,586,603 | |
| 6 | MRK |
Merck & Co., Inc.
|
718,471 | $92,323,523 | |
| 7 | AMGN |
Amgen Inc
|
135,233 | $48,970,573 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
465,263 | $26,808,454 |
All Filings in PFE
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $153,696,066 | 6,382,727 | Shares | Defined | 2026-09-08 | |
| No filing history on record for this holder in this stock. | ||||||